家族性甲状腺结节病易感性的遗传异质性
本研究对8个家系中28例甲状腺滤泡结节病(TFND)患者进行全外显子测序,采用跨家系和家系内分析寻找罕见种系变异。跨家系分析未发现明确候选基因;家系特异性分析在一个家系中发现DICER1截短变异,另一家系一例患者发现SLC26A4杂合变异及组织杂合性缺失,一个家系发现WFS1致病性变异。研究提示TFND具有显著遗传异质性,多为多因素病因。
要点
- 家族性TFND存在显著遗传异质性,多数家系无明确单基因病因。
- DICER1截短变异可解释一个家系的家族性疾病,且与早发相关。
- SLC26A4变异可能通过体细胞二次打击机制致病,但不解释家族聚集。
核心结论
- 家族性TFND具有显著遗传异质性,多数家系缺乏明确单基因病因。
- DICER1可解释一个家系的家族性疾病,SLC26A4支持单个患者的体细胞二次打击机制。
- TFND可能代表更广泛遗传综合征的表型表现,支持多因素病因。
研究设计与样本
- 对8个家系中28例受累个体的种系DNA进行全外显子测序(WES)。
- 采用跨家系分析检测多个家系共享的破坏基因,并采用家系内分析识别分离的罕见致病变异。
- 对4份可获得的TFND组织进行体细胞测序,寻找二次打击机制或拷贝数改变(CNA)。
主要发现
- 跨家系分析发现一个携带意义不明变异的基因,但未成为明确候选。
- 一个家系中发现DICER1截短变异,该家系此前与MNG-1位点关联且与早发疾病相关。
- 另一家系仅一例受累个体发现SLC26A4杂合变异,且该患者组织存在杂合性缺失。
- 一个家系发现WFS1致病性变异,支持其作为TFND候选基因但需进一步验证。
- 所有家系的种系CNA分析及靶向PLCB1筛查均为阴性。
临床怎么用
- 对家族性TFND患者可考虑基因检测,但需注意多数家系无明确单基因病因。
- 发现DICER1变异时应注意家族性甲状腺结节病及潜在相关综合征的评估。
- SLC26A4变异需结合肿瘤组织检测以评估体细胞二次打击机制。
局限性
- 研究样本量有限,仅纳入8个家系28例受累个体。
- 仅4份TFND组织可用于体细胞测序,功能验证不足。
- WFS1等候选基因需进一步验证,多数家系遗传病因未明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nontoxic multinodular goiter (MNG), recently reclassified as thyroid follicular nodular disease (TFND), is a common thyroid disorder with complex and incompletely understood genetic contributors. Although familial aggregation and genetic predisposition have been observed, the underlying molecular mechanisms remain only partially defined. OBJECTIVE: To identify rare germline genetic variants contributing to familial euthyroid TFND, including families with pedigrees suggestive of autosomal dominant inheritance, using whole-exome sequencing (WES). METHODS: WES was performed on germline DNA from 28 affected individuals belonging to eight pedigrees exhibiting TFND. Two analytical approaches were applied, including a cross-pedigree analysis to detect disrupted genes shared across multiple kindreds and kindred-based analyses to identify rare pathogenic variants segregating within individual pedigrees or single affected individuals. Somatic sequencing of four available TFND tissues was also performed to search for second-hit mechanisms or copy number alterations (CNA). RESULTS: Cross-pedigree analysis identified one gene carrying variants of uncertain significance, which did not emerge as definitive candidates. Pedigree-specific analyses revealed a truncating DICER1 variant in a kindred previously linked to the MNG-1 locus and associated with early disease onset; a heterozygous SLC26A4 variant in only one affected individual from another kindred and loss of heterozygosity in the patient's tissue; and a pathogenic WFS1 variant in one kindred, supporting its previously proposed role as a TFND candidate gene, but requiring further validation. Both germline CNA analysis and targeted PLCB1 screening in all kindreds yielded negative results. CONCLUSIONS: This study highlights the substantial genetic heterogeneity underlying familial TFND. While most kindreds lacked clear monogenic causes, DICER1 explained familial disease in one pedigree, whereas the SLC26A4 findings supported a likely somatic second-hit mechanism in a single affected member of another pedigree without accounting for the familial aggregation. The findings support a multifactorial etiology and suggest that TFND represents a phenotypic manifestation within broader hereditary syndromes. Integrating family-based sequencing with functional validation will be critical to fully delineate pathogenic mechanisms and broaden the spectrum of genes implicated in thyroid nodular disease.
引用
- Chong AS, Paschke R, Munté E, et al. Genetic Heterogeneity in Susceptibility to Familial Thyroid Nodular Disease. Thyroid. 2026. PMID: 42723469. doi:10.1177/10507256261485457
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。